Search

everythinglearnresearchcommunity

for

Search:↓

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Drugs like PDEI may help hair disorders like AGA.

Two methods reliably measure scalp area and hair count.

A hair transplant using hair from the back of the head and pubic area was successful in creating a feminine hairline for a male-to-female transgender person.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

An improved scalp reduction technique reduces the need for hair grafts and has minimal complications.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Understanding scalp anatomy is crucial for successful and safe scalp surgery.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Using tissue expanders and hyaluronidase in scalp reduction surgery allows for more scalp removal and easier surgery.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Hair from balding and non-balding areas regrows similarly on mice.